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Ben AR LinaAbstract
In a recent study by Mennitti et al., the authors concluded that oligofructose supplementation during pregnancy
and lactation impairs offspring development.
However, the data reported in this article have limitations and should be interpreted with caution. A conclusion
with respect to offspring development does not seem justified.
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This commentary challenges the conclusion by Menitti
et al. [1] in a recent article entitled: ‘Oligofructose
supplementation during pregnancy and lactation impairs
offspring development and alters the intestinal properties
of 21-d-old pups’.
In this study, groups of 4 pregnant female Wistar rats
were given 10% oligofructose in the diet during pregnancy
and lactation. Oligofructose was incorporated at the
expense of corn starch in AIN-93 based diet. On the
day of delivery, litters were culled to 8 pups each.
During the 21 day lactation period, reduced body
weight, body weight gain and reduced naso-anal length
were reported in the offspring of dams fed the 10%
oligofructose diet. In addition, retroperitoneal adipose
tissue and serum concentrations of free fatty acids
were reported to be decreased in pups of this group.
The authors concluded that oligofructose supplemen-
tation during pregnancy and lactation impairs offspring
development.Main text
In this commentary I would like to challenge the correct-
ness of the conclusion in the paper by Mennitti et al., 2014
that oligofructose supplementation during pregnancy and
lactation impairs offspring development. In my opinion,
this paper suffers from several serious limitations.Correspondence: ben.lina@tno.triskelion.nl
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There were only 4 dams per group, whereas, for a mean-
ingful evaluation, international guidelines require much
larger group sizes e.g. a minimum of 8 pregnant females
for a Reproduction/Developmental Toxicity Screening
Test (OECD 421) [2], at least 16 pregnant females per
group for a Prenatal Developmental Toxicity Study
(OECD 414) [3], or 20 pregnant rats for Developmental
Toxicity Studies according to EPA [4] or FDA [5].
Maternal data
Apart from the statement that ‘10% oligofructose supple-
mentation triggered diarrhea in dams’, no information
on maternal weight, feed intake or maternal toxicity was
provided. This lack of information hampers evaluation
of effects in pups.
Experimental diets
The experimental diets were stated to be isocaloric
(4.0 kcal/g). However, assuming an energetic value of
1.5 kcal/g for oligofructose and 4 kcal/g for corn starch,
the incorporation of 10% oligofructose at the expense of
corn starch results in a lower energetic value of the test
diet (3.75 versus 4.0 kcal/g diet in controls). Because,
moreover, no feed intake figures were presented, it is not
possible to compare the energy intake in the different
groups.
Number of litters, litter size and selection of the pups
No information was provided on the selection of the pups
on the day of delivery, nor on the number of selected pupsis an Open Access article distributed under the terms of the Creative Commons
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minant for the growth rate of pups. Because of this lack of
information, no conclusion can be drawn with respect to
the growth and size of the pups.
Number of pups per group
Only a very limited number of pups was evaluated.
According to the information provided, maximally 32
pups could be available per group. However, only 21
per group were evaluated for growth and length, while
determination for adipose tissue, liver weight and serum
free acid levels were conducted in 10-15 pups. The reason
for selecting or rejecting pups was not reported.
Conclusion
The data reported in this article have limitations and
should be interpreted with caution. A conclusion with
respect to offspring development does not seem justified.
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